ClinicalTrials.govpublic full text
Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
seasonal allergic rhinitis (sar), gsp 301 nasal spray for the treatment of seasonal allergic rhinitis, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828017
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.